Bromobenzene

Bromobenzene

SCHEMBL27532115

Brc1ccccc1.O=CCBr

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ MAPK1 P28482 1/20 0.42
▸ CYP2A6 P11509 2/20 0.38
▸ TRPA1 O75762 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTR2A P28223 1/20 0.37
▸ GSK3B P49841 2/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ ADH1B P00325 1/20 0.34
▸ ADH1C P00326 1/20 0.34
▸ ADH1A P07327 1/20 0.34
▸ ADH7 P40394 1/20 0.34
▸ GPR52 Q9Y2T5 1/20 0.34
▸ PDPK1 O15530 1/20 0.34
▸ G6PD P11413 1/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromobenzene SCHEMBL27865282 0.82 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1CYP2A6TSHR
Bromobenzene SCHEMBL28023281 0.82 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1CYP2A6TSHR
Bromobenzene SCHEMBL27516855 0.80 ALDH1A1 (0.69) ALDH1A1TDP1MAPK1CYP2A6TRPA1
Bromobenzene SCHEMBL27552528 0.80 ALDH1A1 (0.69) ALDH1A1TDP1MAPK1CYP2A6TRPA1
Bromobenzene SCHEMBL27933094 0.80 ALDH1A1 (0.69) ALDH1A1TDP1MAPK1CYP2A6TRPA1
Bromobenzene SCHEMBL28531879 0.80 — —
Bromobenzene SCHEMBL9418037 0.78 ALDH1A1 (0.50) ALDH1A1TDP1MAPK1CYP2A6TSHR
Bromobenzene SCHEMBL22041640 0.78 ALDH1A1 (0.65) ALDH1A1TDP1MAPK1CYP2A6TRPA1
Bromobenzene SCHEMBL27288927 0.78 ALDH1A1 (0.65) ALDH1A1TDP1MAPK1CYP2A6MAOA
Bromobenzene SCHEMBL27260817 0.78 ALDH1A1 (0.65) ALDH1A1TDP1MAPK1CYP2A6TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1930159-A Novel dicationic imidazo [1, 2-a ] pyridine and 5,6,7, 8-tetrahydro-imidazo [1, 2-a ] pyridine compounds as antiprotozoal agents UNIV NORTH CAROLINA (US) 2007-03-14 — — CN claimed
CN-103408537-A 5-substituted dihydrobenzofuran-imidazolium salt compound and preparation method thereof UNIV YUNNAN 2013-11-27 — — CN disclosed
CN-101346336-B 1, 3-di (substituted phenyl) -3-substituted-2-propen-1-one compounds and salts thereof NISSAN CHEMICAL IND LTD 2013-02-27 — — CN disclosed
CN-102766135-A Dihydrofuran indenoane-imidazole salts compound and preparation method thereof UNIV YUNNAN 2012-11-07 — — CN disclosed
CN-102757424-A 2-benzyl-substituted-benzofuran-imidazolium compounds and preparation method thereof UNIV YUNNAN 2012-10-31 — — CN disclosed
CN-102473857-A Organic electroluminescent element IDEMITSU KOSAN CO 2012-05-23 — — CN disclosed
CN-102471269-A Nitrogen-containing heterocyclic derivative and organic electroluminescent element containing same IDEMITSU KOSAN CO 2012-05-23 — — CN disclosed
CN-102471340-A Imidazopyridine derivative and organic electroluminescent element comprising same IDEMITSU KOSAN CO 2012-05-23 — — CN disclosed
CN-101340893-B Intranasal administration of rapid acting insulin NASTECH PHARM CO 2012-03-21 — — CN disclosed
CN-102274272-A Triterpene compositions and methods for use thereof — 2011-12-14 — — CN disclosed
CN-1735605-A Phenylalanine derivative is used for the treatment of or prevent diabetes as depeptidyl peptidase inhibitors MERCK & CO INC (US) 2006-02-15 — — CN disclosed
CN-1726044-A Compositions and methods for enhancing mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity NASTECH PHARM CO (US) 2006-01-25 — — CN disclosed
CN-1681763-A Chemical compounds ASTRAZENECA AB (SE) 2005-10-12 — — CN disclosed
CN-1639145-A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders BAYER PHARMACEUTICALS CORP (US) 2005-07-13 — — CN disclosed
CN-1582287-A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors FUJISAWA PHARMACEUTICAL CO (JP) 2005-02-16 — — CN disclosed
CN-1496255-A Inhibition of NF-KB by triterpene compositions �������о�����չ˽�����޹�˾ 2004-05-12 — — CN disclosed
CN-1368970-A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase KNOLL GMBH (DE) 2002-09-11 — — CN disclosed
CN-1314899-A Retinoid-associated receptor regulators TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-09-26 — — CN disclosed
CN-1307473-A Triterpene compositions and methods of their use RES DEV FOUDATION (US) 2001-08-08 — — CN disclosed
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 — — CN disclosed
Send feedback